Emergence and global spread of epidemic healthcare-associated Clostridium difficile
- PMID: 23222960
- PMCID: PMC3605770
- DOI: 10.1038/ng.2478
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
Abstract
Epidemic C. difficile (027/BI/NAP1) has rapidly emerged in the past decade as the leading cause of antibiotic-associated diarrhea worldwide. However, the key events in evolutionary history leading to its emergence and the subsequent patterns of global spread remain unknown. Here, we define the global population structure of C. difficile 027/BI/NAP1 using whole-genome sequencing and phylogenetic analysis. We show that two distinct epidemic lineages, FQR1 and FQR2, not one as previously thought, emerged in North America within a relatively short period after acquiring the same fluoroquinolone resistance-conferring mutation and a highly related conjugative transposon. The two epidemic lineages showed distinct patterns of global spread, and the FQR2 lineage spread more widely, leading to healthcare-associated outbreaks in the UK, continental Europe and Australia. Our analysis identifies key genetic changes linked to the rapid transcontinental dissemination of epidemic C. difficile 027/BI/NAP1 and highlights the routes by which it spreads through the global healthcare system.
Figures
Comment in
-
Infection: Understanding how Clostridium difficile infection in health-care settings spread around the world.Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):65. doi: 10.1038/nrgastro.2012.249. Epub 2012 Dec 18. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23247509 No abstract available.
-
Clostridium difficile healthcare-associated epidemics.Nat Genet. 2013 Jan;45(1):6-7. doi: 10.1038/ng.2499. Nat Genet. 2013. PMID: 23268129 No abstract available.
References
-
- Bartlett JG. Clostridium difficile: progress and challenges. Ann N Y Acad Sci. 2010;1213:62–69. - PubMed
-
- Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008;359:1932–1940. - PubMed
-
- Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl 6):2–18. - PubMed
-
- Warny M, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079–1084. - PubMed
-
- Riggs MM, et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45:992–998. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
